The short version of Synthetic peptide fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2025-10-08. Anything still debated is marked as such rather than presented as settled.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
| Property | Value | Notes |
|---|---|---|
| Study species | Rodents, mainly rats | Most reports use surgically induced injury models |
| Typical administration route | Subcutaneous or intraperitoneal injection | Routes differ between reports, which complicates comparison |
| Human trial evidence | Limited, small-scale reports | No large randomized trial in indexed journals |
| Reported outcome categories | Mucosal healing, tendon repair, vascular recovery | Endpoints are not standardized across studies |
| Mechanism status | Not established | Proposed pathways lack direct confirmation |
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
Long-term storage of the dry powder is typically described at minus twenty degrees Celsius or colder, while shorter holding periods may use ordinary refrigeration. Repeated warming and cooling cycles are discouraged because they stress the material and can promote aggregation or loss. Light exposure and residual moisture are both treated as avoidable sources of degradation, and working aliquots are often prepared to limit how many times a container is opened. Sealed vials with a desiccant are the usual container.
Quality assessment rests on two separate questions: whether the chain is the intended one, and how much of the sample is that chain. Reverse-phase high-performance liquid chromatography with ultraviolet detection is the standard purity measurement, while mass spectrometry confirms identity through the observed molecular mass. Amino acid analysis and sequence verification provide further checks. A reported purity percentage describes the proportion of the sample represented by the main peak, not the amount of peptide by mass, since counter-ions and water make up part of any lyophilized lot.
== Terminology == Buff – Having high amount of muscle mass Recovery – Resting time after workout to avoid muscle fatigue Reps – Short for repetitions, usually referred to strength training exercises Ripped – Having very low body fat percentage accompanied with high amount of muscle mass Sets – Repetitions done for certain amount followed by a period of rest Warm up – Initial exercises done to prepare for the main routine Workout – Routine of multiple exercises Gains - Muscle mass gained after a period of working out Nutritional Amino acid Creatine Dietary supplement Energy drink Formula Protein Snack bar Vitamin B12 Vitamin B2 Vitamin B6 Whey protein Biological Joint Muscle Muscle fiber Muscle tissue Tendon
=== Portugal === The Portuguese parliament is called the Assembleia da República. A member of parliament is known as a deputado, that is, a person who is appointed through democratic election to act on the people's behalf.
f. antarctica (Vain.) Hue (1915) is now Polycauliona antarctica f. ectaneoides (Nyl.) Boistel (1903) is now Xanthoria ectaneoides f. ectaniza Boistel (1903) is now Rusavskia ectaniza f. polycarpa (Hoffm.) Arnold (1881) is now Polycauliona polycarpa subsp. calcicola (Oxner) Clauzade & Cl.Roux (1985) is now Xanthoria calcicola subsp. phlogina (Ach.) Sandst. (1912) is now Scythioria phlogina var. aureola (Ach.) Th.Fr. (1860) is now Xanthoria aureola var. australis Zahlbr. (1917) is now Jackelixia australis var. contortuplicata (Ach.) H.Olivier (1894) is now Xanthaptychia contortuplicata var. incavata (Stirt.) Js. Murray (1960) is now Dufourea incavata var. lobulata (Flörke) Rabenh. (1870) is now Seawardiella lobulata var. mandschurica Zahlbr. (1931) is now Zeroviella mandschurica var. rutilans (Ach.) Maheu & A.Gillet (1924) is now Xanthoria rutilans
== See also == Chronic diseases and cancers linked to infectious microbes List of oncogenic bacteria List of epidemics and pandemics List of causes of death by rate − including specific infectious diseases and classes thereof List of human disease case fatality rates List of vaccine topics
Sources: en.wikipedia.org
The budget of the European Union is set in 7 year cycles, and in 2022 around €170bn was spent, of which nearly one-third was agricultural policy, including regional development. EU member state government expenditures are far higher as a proportion of Gross Domestic Product, but are constrained by the Fiscal Compact, which requires no more than a 3% budget deficit compared to GDP in any given year, and aiming for surpluses or balanced budgets. As a result of the Eurozone crisis, a Treaty establishing the European Stability Mechanism created a fund to assist countries with severe fiscal problems. The results of the "strict conditionality" attached to loans (or so called structural adjustment) that required privatisation, cuts to welfare, and wages in Greece, Spain, Portugal or Ireland was particularly negative. The EU's main metric for economic performance has been GDP, which adds up market exchange values in firm accounts and government expenditures according to the Gross National Income Regulation 2019, even though this fails to discount polluting and harmful economic activities such as energy and industry that damages the climate, the environment and human health. The EU's budget mainly comes from contributions of around 0.7% of GDP per member state, as well as a share of EU value added tax and customs duties. The EU does not yet have a more comprehensive system for preventing tax evasion, or for fair taxation of multinational or financial corporations.
The soft tissue in the oral cavity is classified as either keratinized or nonkeratinized based on the presence of keratin in the epithelium. In health, the soft tissue immediately around the teeth is keratinized and is referred to as keratinized tissue or gingiva. Alveolar mucosa is non keratinized oral epithelium and is located apical to the keratinized tissue, delineated by the mucogingival junction (MGJ). It should also be pointed out that mucosa can surround a tooth in health. Nonkeratinized tissue also lines the cheeks (buccal mucosa), underside of the tongue and floor of the mouth. The lips contain both non-keratinized tissue (on the inside) and keratinized tissue on the outside, demarcated by the vermillion border. The dorsum of the tongue is keratinized and features many papillae, some of which contain taste buds. Exposure of the tooth root due to loss of keratinized tissue around the neck of a tooth is referred to as gingival recession. This can result in sensitivity or pain from the exposed tooth root surface (dentin is more permeable and soft compared to enamel and dentin is what makes up the tooth root). Recession may also cause an unasthetic appearance especially if located in the anterior dentition (front teeth). While not all cases of gingival recession require surgical correction, there are various options if that is what the patient desires. It should be reinforced that recession left untreated will not result in tooth loss, contrary to popular belief.
Blood plasma is a light amber-colored liquid component of blood in which blood cells are absent, but which contains proteins and other constituents of whole blood in suspension. It makes up about 55% of the body's total blood volume. It is the intravascular part of extracellular fluid (all body fluid outside cells). It is mostly water (up to 95% by volume), and contains important dissolved proteins (6–8%; e.g., serum albumins, globulins, and fibrinogen), glucose, clotting factors, electrolytes (Na+, Ca2+, Mg2+, HCO3−, Cl−, etc.), hormones, carbon dioxide (plasma being the main medium for excretory product transportation), and oxygen. It plays a vital role in an intravascular osmotic effect that keeps electrolyte concentration balanced and protects the body from infection and other blood-related disorders. Blood plasma can be separated from whole blood through blood fractionation, by adding an anticoagulant to a tube filled with blood, which is spun in a centrifuge until the blood cells fall to the bottom of the tube. The blood plasma is then poured or drawn off. For point-of-care testing applications, plasma can be extracted from whole blood via filtration or via agglutination to allow for rapid testing of specific biomarkers. Blood plasma has a density of approximately 1,025 kg/m3 (1.025 g/ml). Blood serum is blood plasma without clotting factors. Plasmapheresis is a medical therapy that involves blood plasma extraction, treatment, and reintegration.
Sources: en.wikipedia.org
== Legal status == DNP is banned for human consumption in many countries. Because it has some legitimate uses, in many jurisdictions, DNP is legal to sell, but not for human consumption. DNP has been banned by the World Anti-Doping Association since 2015. Petróczi et al. recommend against campaigns informing people of the risks of DNP because it could increase use of the drug. However, Sousa et al. argue that publicity campaigns in the United Kingdom in the early and mid-2010s reduced DNP usage. In 2015, Interpol and the World Anti-Doping Agency released an orange notice warning of the dangers of DNP. In 1941, the Eastman Kodak Company, a bulk distributor of DNP, was investigated after some of its product was found in illegal diet pills. Nicholas Bachynsky, a Texas physician, provided the drug to patients under the name "Mitcal". He was convicted of violating drug laws in 1986, but continued to work with DNP and was additionally convicted of fraud in 2008. In 2018, a seller in the United Kingdom was convicted of manslaughter for selling DNP for human consumption. The conviction was sent to retrial in 2020 by the English Court of Appeal, where the seller was, once again, convicted of gross negligence manslaughter. The UK government reclassified DNP as a regulated poison with effect from October 2023.
12 September – Bill Wilson, lawyer and judge, judge of the Court of Appeal (2007–2008) and Supreme Court (2008–2010), King's Counsel (since 1996) (born 1946). 13 September – Stan Simpson, wool scientist (WRONZ) and science administrator, director of WRONZ (1978–1992) (born 1933). 14 September – Barry Roberts, cricketer (Northern Districts) (born 1946). 16 September Judy Tinnock, tennis player, Wimbledon mixed doubles semi-finalist (1954) (born 1931). Jack Williams, cricketer (Canterbury) (born 1931). 17 September Tenick Dennison, paediatrician, conservationist and ornithologist (born 1927). Jim Easton, oldest living man in New Zealand (108 years, 279 days), oldest living Australian World War II veteran (born 1916). Dame Joan Metge, social anthropologist (University of Auckland, Victoria University of Wellington), Te Rangi Hiroa Medal (1997) (born 1930). 20 September – Tui Te Rupe, Paralympic marathon runner (1988) (born 1943). 21 September Stu Freebairn, rugby union player (Manawatu, national team) (born 1932). William E. Shepard, religious studies academic (University of Canterbury) (born 1933). 22 September Ian Farquhar, maritime historian, businessman and local politician, chair of the Otago Harbour Board (1980–1983) (born 1931). Grant Hawke, Māori leader (Ngāti Whātua Ōrākei) (born 1944). 23 September Bruce Morrison, cricketer (Wellington, national team) (born 1933). Sir Tumu Te Heuheu, Māori leader, paramount chief of Ngāti Tūwharetoa (since 1997) (born 1941). 25 September Glynn Jones, physicist (University of Canterbury) (born 1936).
Postcentral gyrus The gyrus in the parietal lobe that contains the primary somatosensory cortex, responsible for processing tactile information from the body. Posterior parietal cortex A region involved in integrating sensory information for spatial awareness and movement planning. Important in reaching and grasping tasks. Postganglionic neuron A neuron in the autonomic nervous system that extends from a ganglion to a target organ, influencing functions such as heart rate and digestion. Postsynaptic potential A change in membrane potential in a neuron following activation of synaptic receptors. Can be excitatory (EPSP) or inhibitory (IPSP). Prefrontal cortex The front part of the frontal lobe involved in decision-making, planning, social behavior, and personality. Highly developed in humans. Presynaptic terminal The end of an axon where neurotransmitters are released into the synaptic cleft following an action potential. Primary motor cortex A region in the frontal lobe responsible for initiating voluntary motor movements. Located in the precentral gyrus. Primary somatosensory cortex Located in the postcentral gyrus of the parietal lobe, it processes tactile and proprioceptive information from the body. Prion A misfolded protein that can cause other proteins to misfold, leading to neurodegenerative diseases such as Creutzfeldt–Jakob disease. Procedural memory A type of long-term memory for performing tasks and skills (e.g., riding a bike), often associated with the basal ganglia and cerebellum.
Sources: en.wikipedia.org
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.
Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.
Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.